AlphaCentric Life Sciences and Healthcare Fund Class A (LYFAX)
Fund Assets | 99.21M |
Expense Ratio | 1.66% |
Min. Investment | $2,500 |
Turnover | n/a |
Dividend (ttm) | 0.23 |
Dividend Yield | 1.74% |
Dividend Growth | -26.86% |
Payout Frequency | Semi-Annual |
Ex-Dividend Date | Dec 30, 2024 |
Previous Close | 13.17 |
YTD Return | 4.79% |
1-Year Return | 5.90% |
5-Year Return | 81.81% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | 0.60 |
Holdings | 61 |
Inception Date | Nov 29, 2019 |
About LYFAX
LYFAX was founded on 2019-11-29. The Fund's investment strategy focuses on Health/Biotech with 1.66% total expense ratio. The minimum amount to invest in Mutual Fund Series Trust: AlphaCentric LifeSci Healthcare Fund; Class A Shares is $2,500 on a standard taxable account. Mutual Fund Series Trust: AlphaCentric LifeSci Healthcare Fund; Class A Shares seeks long-term capital appreciation. LYFAX invests in equity securities of companies in life sciences and healthcare sectors, which consists of companies related to producing facilities, supplies, technology, pharmaceuticals, equipment and services for the preservation and care of a persons health.
Performance
LYFAX had a total return of 5.90% in the past year. Since the fund's inception, the average annual return has been 10.11%, including dividends.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Symbol | Provider | Name | Expense Ratio |
---|---|---|---|
undefined | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
undefined | Fidelity | Fidelity Select Health Care Portfolio | 0.65% |
undefined | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
undefined | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
undefined | Fidelity | Fidelity Select Health Care Services Portfolio | 0.68% |
Top 10 Holdings
47.99% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 9.00% |
UnitedHealth Group Incorporated | UNH | 6.84% |
Johnson & Johnson | JNJ | 4.99% |
AbbVie Inc. | ABBV | 4.39% |
Merck & Co., Inc. | MRK | 4.27% |
Thermo Fisher Scientific Inc. | TMO | 4.12% |
AstraZeneca PLC | AZN | 3.94% |
Novo Nordisk A/S | NVO | 3.81% |
First American Treasury Obligations Fund | FXFXX | 3.46% |
Boston Scientific Corporation | BSX | 3.17% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 30, 2024 | $0.0176 | Dec 31, 2024 |
Dec 13, 2024 | $0.2313 | Dec 16, 2024 |
Dec 14, 2023 | $0.3403 | Dec 15, 2023 |
Dec 15, 2022 | $0.5494 | Dec 16, 2022 |
Dec 16, 2021 | $1.6524 | Dec 16, 2021 |
Dec 17, 2020 | $0.3512 | Dec 17, 2020 |